Sign In
Last checked at 
4 Feb 2009 12:32
ο»Ώ
|
For Immediate Release |
4 February 2009 |
ImmuPharma PLC
Grant of Options
ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company,Β grantedΒ todayΒ share options toΒ certain ofΒ itsΒ employees andΒ Directors. The Company has adopted a HM Revenue & Customs approved share ownership plan (CSOP) and an unapproved share option scheme.
The amount of options granted are summarised in the following table:
|
Director |
Options Granted |
|
Richard Warr |
140,000 |
|
Robert Zimmer |
150,000 |
|
Dimitri Dimitriou |
140,000 |
|
Franco di Muzio |
100,000 |
|
Ajay Agrawal |
100,000 |
The share options provide the right to subscribeΒ forΒ ordinary sharesΒ of 10 pence each in the CompanyΒ atΒ a price ofΒ 86.5Β pence each, the closing middleΒ market priceΒ on 3 February 2009. The options are exercisableΒ betweenΒ 3 years and 10 years fromΒ the date ofΒ grant.
For further information, please contact:
ImmuPharma PLC
Dimitri Dimitriou, Chief Executive Officer 020 7152 4080
Richard Warr, Chairman 020 7152 4080
Dr Robert Zimmer, President & Chief Scientific Officer +33 389 32 76 50
Panmure Gordon & CoΒ (Nominated AdvisorΒ and Broker)
Andrew Burnett / Rakesh Sharma (Corporate Finance)Β 020 7459Β 3600
Ashton Clanfield (Corporate Broking)
Buchanan Communications Β 020 7466 5000
Lisa Baderoon
Rebecca Skye Dietrich
Follow the stocks
